Ernst Kriehuber MD

Ernst Kriehuber received his MD degree from Medical University Vienna. He worked with Peter Elias (UCSF) on the permeability barrier of the skin and with Georg Stingl (Medical University Vienna) and Giulio Superti-Furga (CeMM) on immunemechanisms in skin inflammation. Ernst joined Novartis in 2010 and held different positions in discovery and translational research. Among others, Ernst has led a Novartis Institutes for BioMedical Research site dedicated to dermatologic drug discovery in Vienna, Austria, before joining the companies’ headquarters in Basel, Switzerland. In Basel, Ernst has so far has contributed to strategic outlines of NIBR’s dermatology and respiratory TA and DA strategies and was part of leadership teams and decision boards. In addition, Ernst was leading teams of translational and computational biologists to explore novel indications and druggable nodes in dermatology and other therapeutic areas. Currently Ernst holds responsibilities for the preclinical dermatology portfolio and business development activities for dermatology.